Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cl 68
2. Clocortolone Trimethylacetate
3. Cloderm
4. Purantix
1. 34097-16-0
2. Clocortolone 21-pivalate
3. Cloderm
4. Sh 863
5. Qbl8izh14x
6. Purantix
7. Clocortolone Pivalate (200 Mg)
8. Mls002154165
9. [2-[(6s,8s,9r,10s,11s,13s,14s,16r,17s)-9-chloro-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6h-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate
10. Chebi:59583
11. Sh-863
12. 9-chloro-6alpha-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-pivalate
13. Cilder
14. Cl 68
15. 9-chloro-6alpha-fluoro-11beta-hydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl 2,2-dimethylpropanoate
16. Unii-qbl8izh14x
17. Clocortolone Pivalate [usan]
18. Clocortolone Pivalate [usan:usp]
19. Ncgc00016824-01
20. Pregna-1,4-diene-3,20-dione, 9-chloro-21-(2,2-dimethyl-1-oxopropoxy)-6-fluoro-11-hydroxy-16-methyl-, (6.alpha.,11.beta.,16.alpha.)-
21. Clocortolone-pivalate
22. Cloderm (tn)
23. Einecs 251-826-5
24. Cas-34097-16-0
25. Prestwick0_001119
26. Prestwick1_001119
27. Prestwick2_001119
28. Prestwick3_001119
29. Schembl5120
30. Dsstox_cid_25460
31. Dsstox_rid_80891
32. Clocortolone Pivalate (usp)
33. Dsstox_gsid_45460
34. Bspbio_001258
35. Spbio_003119
36. Bpbio1_001383
37. Chembl1200975
38. Dtxsid0045460
39. Hms1571o20
40. Hms2098o20
41. Hms2236m06
42. Hms3715o20
43. 9-chloro-6.alpha.-fluoro-11.beta.,21-dihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione 21-pivalate
44. Zinc4212603
45. Tox21_110632
46. Clocortolone Pivalate [vandf]
47. Clocortolone Pivalate [mart.]
48. Clocortolone Pivalate [usp-rs]
49. Clocortolone Pivalate [who-dd]
50. Ccg-221119
51. Clocortolone 21-pivalate [mi]
52. Ncgc00179239-01
53. Ncgc00179239-05
54. Smr001233464
55. Clocortolone Pivalate [orange Book]
56. Ab00514058
57. Clocortolone Pivalate [usp Monograph]
58. D02287
59. Sr-01000838872
60. Sr-01000838872-2
61. Brd-k38003476-001-03-4
62. Q39045318
63. (6alpha,11beta,16alpha)-9-chloro-21-(2,2-dimethyl-1-oxopropoxy)-6-fluoro-11-hydroxy-16-methypregna-1,4-diene-3,20-dione
64. 9-chloro-6
65. A-fluoro-11
66. A,21-dihydroxy-16
67. A-methylpregna-1,4-diene-3,20-dione 21-pivalate Pound Clocortolone Pivalate)
68. 9alpha-chloro-6alpha-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-pivalate
69. Pregna-1,4-diene-3,20-dione, 9-chloro-21-(2,2-dimethyl-1-oxopropoxy)-6-fluoro-11-hydroxy-16-methyl-, (6alpha,11beta,16alpha)-
Molecular Weight | 495.0 g/mol |
---|---|
Molecular Formula | C27H36ClFO5 |
XLogP3 | 4.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Exact Mass | 494.2235301 g/mol |
Monoisotopic Mass | 494.2235301 g/mol |
Topological Polar Surface Area | 80.7 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 982 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Cloderm |
PubMed Health | Clocortolone Pivalate (On the skin) |
Drug Classes | Corticosteroid, Weak |
Drug Label | Cloderm Cream 0.1% contains the medium potency topical corticosteroid, clocortolone pivalate, in a specially formulated water-washable emollient cream base consisting of purified water, white petrolatum, mineral oil, stearyl alcohol, polyoxyl 40 stea... |
Active Ingredient | Clocortolone pivalate |
Dosage Form | Cream |
Route | Topical |
Strength | 0.1% |
Market Status | Prescription |
Company | Promius Pharma |
2 of 2 | |
---|---|
Drug Name | Cloderm |
PubMed Health | Clocortolone Pivalate (On the skin) |
Drug Classes | Corticosteroid, Weak |
Drug Label | Cloderm Cream 0.1% contains the medium potency topical corticosteroid, clocortolone pivalate, in a specially formulated water-washable emollient cream base consisting of purified water, white petrolatum, mineral oil, stearyl alcohol, polyoxyl 40 stea... |
Active Ingredient | Clocortolone pivalate |
Dosage Form | Cream |
Route | Topical |
Strength | 0.1% |
Market Status | Prescription |
Company | Promius Pharma |
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
79
PharmaCompass offers a list of Clocortolone Pivalate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clocortolone Pivalate manufacturer or Clocortolone Pivalate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clocortolone Pivalate manufacturer or Clocortolone Pivalate supplier.
PharmaCompass also assists you with knowing the Clocortolone Pivalate API Price utilized in the formulation of products. Clocortolone Pivalate API Price is not always fixed or binding as the Clocortolone Pivalate Price is obtained through a variety of data sources. The Clocortolone Pivalate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cloderm manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cloderm, including repackagers and relabelers. The FDA regulates Cloderm manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cloderm API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cloderm manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cloderm supplier is an individual or a company that provides Cloderm active pharmaceutical ingredient (API) or Cloderm finished formulations upon request. The Cloderm suppliers may include Cloderm API manufacturers, exporters, distributors and traders.
click here to find a list of Cloderm suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cloderm DMF (Drug Master File) is a document detailing the whole manufacturing process of Cloderm active pharmaceutical ingredient (API) in detail. Different forms of Cloderm DMFs exist exist since differing nations have different regulations, such as Cloderm USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cloderm DMF submitted to regulatory agencies in the US is known as a USDMF. Cloderm USDMF includes data on Cloderm's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cloderm USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cloderm suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cloderm as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cloderm API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cloderm as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cloderm and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cloderm NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cloderm suppliers with NDC on PharmaCompass.
Cloderm Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cloderm GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cloderm GMP manufacturer or Cloderm GMP API supplier for your needs.
A Cloderm CoA (Certificate of Analysis) is a formal document that attests to Cloderm's compliance with Cloderm specifications and serves as a tool for batch-level quality control.
Cloderm CoA mostly includes findings from lab analyses of a specific batch. For each Cloderm CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cloderm may be tested according to a variety of international standards, such as European Pharmacopoeia (Cloderm EP), Cloderm JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cloderm USP).